Guided by our mission to Making Lives Healthier, Finecure Pharmaceuticals Limited combines advanced formulation science with industrial-scale manufacturing. We produce finished dose formulations across Pharmaceuticals, Nutraceuticals, and OTC products, supported by state-of-the-art Oral Solid Dosage (OSD) infrastructure and a DSIR-approved R&D center.
With a leading branded prescription presence in India and an expanding footprint across 20+ global markets—including North America, Southeast Asia, LATAM, and WANA—we bring the compliance, agility, and scale needed to power global healthcare.
View Corporate Overview
Engineered for Global Compliance
Scaling high-volume commercial production while driving uncompromising QA/QC.
Spanning 15 therapeutic categories, premium nutraceuticals, and complex NDDS.
Active supply chains and MoH registrations across key markets in the US, LatAm, SEA, and Africa.
Uncompromising quality governance aligned with WHO-GMP and USFDA guidelines for zero-defect manufacturing.
Including physically isolated Beta-Lactams and sterile PIC/S compliant injectables.
Specializing in complex reverse-engineering, NDDS formulation, and rapid tech transfers.
Registration-ready supply across 20+ markets including the United States, backed by 100+ international registrations and CTD / eCTD / ACTD dossiers.
Export EnquiryState-of-the-art manufacturing facilities featuring dedicated capacities for Finished Dosage Forms (FDF) across major therapeutic segments—including antibiotics, cardiovascular, respiratory, diabetes, OTC, and nutraceuticals. We support complete product lifecycles, from established formulations to full-scale commercialization.
CDMO EnquiryOut-licensing and P2P co-development from a ready-to-file dossier pipeline, with formulation development under a DSIR-recognised R&D centre.
Licensing EnquiryPartnering with Finecure means aligning with a proven, resilient supply chain. Our domestic success proves our ability to execute at scale in a highly competitive landscape.
Trade Enquiry
Finecure develops Finished dosage formulations across generics, complex generics, NDDS with its mission to “Making Lives Healthier” at its DSIR-recognised R&D centre and these products are manufactured and commercialized at state-of-the-art facilities of Finecure. We engineer cost-efficient, efficacious products at our own plants to make quality healthcare affordable. from its dedicated plants. The company continues to provide the products in Domestic Markets in Branded Formulation Business, and in Overseas Markets as Private Labels, Tech Transfers and Branded Formulations.
Manufacturing capability is organised by molecule class. Each block below produces a defined set of products, with the accreditations applicable to that block stated on every product page it makes.
Dedicated facility for Amoxicillin and Amoxicillin-Clavulanate, featuring a 100% physically isolated block with multiple dosage formulations.
Explore
State-of-the-art, dedicated sterile facility specializing in cephalosporin dry powder injection—manufactured under rigorous quality standards across multiple dosage formats.
Explore
Built on conventional and modified-release platforms, our cardiovascular and anti-diabetic portfolio delivers simple and complex formulations across statins, antiplatelets, and telmisartan, gliptin, gliflozin, and biguanide combinations.
Explore
Comprehensive gastrointestinal and metabolic formulations—including proton-pump inhibitors with prokinetic combinations, vonoprazan, antacids, alginate suspensions, enzyme preparations, and hepatoprotectives—available in oral solid and liquid delivery forms.
Explore
Dedicated manufacturing platforms delivering specialized nutraceutical formulations—including calcium and vitamin D3 systems, iron combinations, protein supplements, and prenatal care.
ExploreFinecure operates state-of-the-art manufacturing facilities across Gujarat and Uttarakhand, designed with strict segregation across key therapeutic segments, including cardiovascular, diabetes, antibiotics, respiratory, OTC, and nutraceuticals.
Annual capacity across these units reaches 4,000 million tablets, 3,000 million capsules, 2,500 tonnes of powder, 30 million powders for oral suspension, 25 million injectables, and 30 million ointments—all driven by high-speed automated lines with GS1-compliant serialization.
Isolated block, independent HVAC, sub-20% relative humidity
Broad solid dosage capabilities: Tablets (Immediate/Sustained-Release & Chewable) and Hard Gelatin Capsules.
Establishment Inspection Report issued
Formulation development and technology transfer to commercial scale
Finecure Pharmaceuticals delivers trusted, innovation-led healthcare brands designed to meet global standards of
quality and efficacy.
Our accolades reflect Finecure’s sustained commitment to pharmaceutical innovation, manufacturing integrity, and global health impact. These recognitions serve as third-party validation of our world-class standards and operational consistency.
Best Healthcare Brand The Economic Times 2026
Zee Architects of Viksit Bharat Award by Hon Deputy CM, Gujarat 2026
Best Healthcare Brand The Economic Times 2023
Entrepreneurship Award for Manufacturing Business-Healthcare & Export By Entrepreneur Magazine
Best of Asia- Most Admired Brand Employer Branding Institute
Dream Companies to Work For World HRD Congress
Excellence in Pharmaceutical Brand Times Ascent Leadership
Finecure supplies 20+ international markets across South East Asia, Africa, WANA, Latin America, and North America. Global market entry is driven by 100+ international product registrations and supported by destination-specific CTD, eCTD, and ACTD dossiers.
Our Regulatory Affairs team continuously monitors USP, BP, and EP pharmacopoeial standards to compile submission packages for Ministry of Health approvals and institutional tenders. By leveraging pre-existing dossiers from comparable registered markets, we streamline approval workflows and accelerate time-to-market.
Markets
Product Registrations
India, North America,Latin America South East Asia, Africa, WANA
For two decades Finecure has manufactured for the pharmaceutical and nutraceutical sectors, both under its own brands and for partners.
Finecure works with international distributors, institutional and tender buyers, licensing partners and contract manufacturing clients. Each enquiry is assessed against the requested market and molecule, and the business development team responds within two working days with a defined supply and regulatory pathway.
Finecure operates a dedicated, state-of-the-art manufacturing site specifically engineered for the high-standard production of amoxicillin-clavulanate. Built as a 100% physically isolated block with completely dedicated production lines, the facility ensures uncompromising product integrity and compliance. It delivers a comprehensive spectrum of paediatric and adult formulations—including capsules, tablets, dispersible tablets, and dry syrups—with precise, published pharmacopoeial designations for every presentation.
Finecure Pharmaceuticals operates as an industrial specialist in high-capacity Oral Solid Dosage (OSD) manufacturing. Our state-of-the-art production blocks are engineered to solve complex formulation challenges, delivering consistent batch-to-batch uniformity, optimal dissolution profiles, and superior drug stability at massive commercial scale.
We provide world-class CDMO and contract manufacturing services for global partners requiring extreme precision and uncompromising quality across pharmaceuticals, nutraceuticals, and OTC products. From rapid technology transfers to continuous high-volume supply, we provide the regulatory certainty and technical bandwidth to excel in competitive international markets.
At Finecure Pharmaceuticals, our workforce is our greatest strategic asset. We have cultivated a high-performance culture where 1,000+ specialized professionals work in synergy to maintain our status as a global pharmaceutical leader.
Our consistent recognition as a 'Dream Company to Work For' by the World HRD Congress is more than an award-it is a guarantee to our global partners that their products are managed by a highly motivated, world-class team dedicated to absolute operational integrity and manufacturing precision.
Stay updated with the latest therapeutic advancements, regulatory milestones, and strategic initiatives driving Finecure’s global expansion.
Validating our sustained commitment to brand trust and market leadership on a global scale.
Strengthening our Anti-Allergic segment with high-efficacy, registration-ready formulations for international markets.
Showcasing our R&D capability in high-demand chronic care molecules with complete CTD/eCTD dossier support.
Investing in the high-tier technical talent required to maintain world-class pharmaceutical standards.
